Bulk Manufacturer of Controlled Substances Application: Cedarburg Pharmaceuticals, Inc., 57390 [2015-24127]
Download as PDF
<![CDATA[
57390
Federal Register / Vol. 80, No. 184 / Wednesday, September 23, 2015 / Notices
registration as an importer of those
controlled substances.
SUPPLEMENTARY INFORMATION: By notice
dated April 14, 2015, and published in
the Federal Register on April 22, 2015,
80 FR 22556, Rhodes Technologies, 498
Washington Street, Coventry, Rhode
Island, 02816 applied to be registered as
an importer of a certain basic classes of
controlled substances. Comments and
request for hearings on applications to
import narcotic raw material are not
appropriate. 72 FR 3417 (January 25,
2007).
The DEA has considered the factors in
21 U.S.C. 823, 952(a) and 958(a) and
determined that the registration of
Rhodes Technologies to import the basic
classes of controlled substances is
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971. The
DEA investigated the company’s
maintenance of effective controls
against diversion by inspecting and
testing the company’s physical security
systems, verifying the company’s
compliance with state and local laws,
and reviewing the company’s
background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the above-named
company is granted registration as an
importer of the following basic classes
of controlled substances:
Controlled substance
Schedule
Opium, raw (9600) ......................
Poppy Straw Concentrate (9670)
II
II
The company plans to import the
listed controlled substances in order to
bulk manufacture controlled substances
in Active Pharmaceutical Ingredient
(API) form. The company distributes the
manufactured APIs in bulk to its
customers.
Dated: September 16, 2015.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2015–24119 Filed 9–22–15; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
mstockstill on DSK4VPTVN1PROD with NOTICES
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: Cedarburg
Pharmaceuticals, Inc.
ACTION:
Notice of application.
VerDate Sep<11>2014
18:00 Sep 22, 2015
Jkt 235001
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.33(a) on
or before November 23, 2015.
Dated: September 16, 2015.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/ODXL, 8701
Morrissette Drive, Springfield, Virginia
22152. Request for hearings should be
sent to: Drug Enforcement
Administration, Attention: Hearing
Clerk/LJ, 8701 Morrissette Drive,
Springfield, Virginia 22152.
DEPARTMENT OF JUSTICE
The
Attorney General has delegated her
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Deputy Assistant
Administrator of the DEA Office of
Diversion Control (‘‘Deputy Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on June
16, 2015, Cedarburg Pharmaceuticals,
Inc., 870 Badger Circle, Grafton,
Wisconsin 53024 applied to be
registered as a bulk manufacturer of the
following basic classes of controlled
substances:
SUMMARY:
DATES:
ADDRESSES:
SUPPLEMENTARY INFORMATION:
Controlled substance
Marihuana (7360) .........................
Tetrahydrocannabinols (7370) .....
4-Anilino-N-phenethyl-4-piperidine
(ANPP) (8333).
Remifentanil (9739) ......................
Fentanyl (9801) ............................
Schedule
I
I
II
II
II
The company plans to manufacture
the above-listed controlled substances
in bulk for distribution to its customers.
In reference to drug code (7360)
marihuana, the company plans to bulk
manufacture cannabidiol as a synthetic
intermediate. This controlled substance
will be further synthesized to bulk
manufacture synthetic
tetrahydrocannabinols (7370). No other
activity for this drug code is authorized
for this registration.
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
[FR Doc. 2015–24127 Filed 9–22–15; 8:45 am]
BILLING CODE 4410–09–P
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Registration: Wildlife Laboratories, Inc.
ACTION:
Notice of registration.
Wildlife Laboratories, Inc.,
applied to be registered as an importer
of certain basic classes of controlled
substances. The Drug Enforcement
Administration (DEA) grants Wildlife
Laboratories, Inc. registration as an
importer of those controlled substances.
By notice
dated June 12, 2015, and published in
the Federal Register on June 23, 2015,
80 FR 35975, Wildlife Laboratories, Inc.,
1230 W. Ash Street, Suite D, Windsor,
Colorado 80550 applied to be registered
as an importer of certain basic classes of
controlled substances. No comments or
objections were submitted for this
notice.
The DEA has considered the factors in
21 U.S.C. 823, 952(a) and 958(a) and
determined that the registration of
Wildlife Laboratories, Inc. to import the
basic classes of controlled substances is
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971. The
DEA investigated the company’s
maintenance of effective controls
against diversion by inspecting and
testing the company’s physical security
systems, verifying the company’s
compliance with state and local laws,
and reviewing the company’s
background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the above-named
company is granted registration as an
importer of the basic classes of
controlled substances:
SUPPLEMENTARY INFORMATION:
Controlled substance
Etorphine (except HCl) (9056) .....
Etorphine HCl (9059) ...................
Schedule
I
II
The company plans to import the
listed controlled substances for sale to
its customer.
E:\FR\FM\23SEN1.SGM
23SEN1
]]>Agencies
[Federal Register Volume 80, Number 184 (Wednesday, September 23, 2015)]
[Notices]
[Page 57390]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-24127]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Application: Cedarburg
Pharmaceuticals, Inc.
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration in accordance with 21 CFR
1301.33(a) on or before November 23, 2015.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/ODXL,
8701 Morrissette Drive, Springfield, Virginia 22152. Request for
hearings should be sent to: Drug Enforcement Administration, Attention:
Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated her
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Deputy Assistant Administrator of the DEA Office of Diversion
Control (``Deputy Assistant Administrator'') pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR 1301.33(a), this is notice that on June
16, 2015, Cedarburg Pharmaceuticals, Inc., 870 Badger Circle, Grafton,
Wisconsin 53024 applied to be registered as a bulk manufacturer of the
following basic classes of controlled substances:
------------------------------------------------------------------------
Controlled substance Schedule
------------------------------------------------------------------------
Marihuana (7360)........................... I
Tetrahydrocannabinols (7370)............... I
4-Anilino-N-phenethyl-4-piperidine (ANPP) II
(8333).
Remifentanil (9739)........................ II
Fentanyl (9801)............................ II
------------------------------------------------------------------------
The company plans to manufacture the above-listed controlled
substances in bulk for distribution to its customers. In reference to
drug code (7360) marihuana, the company plans to bulk manufacture
cannabidiol as a synthetic intermediate. This controlled substance will
be further synthesized to bulk manufacture synthetic
tetrahydrocannabinols (7370). No other activity for this drug code is
authorized for this registration.
Dated: September 16, 2015.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2015-24127 Filed 9-22-15; 8:45 am]
BILLING CODE 4410-09-P
